Literature DB >> 19338538

Bladder cancer survivals in New South Wales, Australia: why do women have poorer survival than men?

Elizabeth Tracey1, David Roder, Colin Luke, James Bishop.   

Abstract

OBJECTIVE: To investigate factors that most influenced survival from bladder cancer in New South Wales, Australia (NSW) and to consider the impact of changes in coding practices on the reporting the of bladder cancer outcomes. PATIENTS AND METHODS: All NSW cases of bladder cancer diagnosed between 1980 and 2003 were followed to the end of 2004 (17 923 cases). Survival analysis was undertaken using Kaplan-Meier unadjusted disease-specific survival and adjusted disease-specific survival using Cox proportional hazards regression modelling. This analysis was unique in that it modelled the effect of sex, age, country of birth, socio-economic status (SES), histological type, extent of disease and period of diagnosis on survival from bladder cancer in NSW.
RESULTS: After adjusting for sex, age, extent of disease, SES, period of diagnosis and histological type, the likelihood of death was 11% (95% confidence interval, CI 5-18%) higher in females than in males, with case fatality most influenced by age at diagnosis, extent of disease, and histological type. When the analysis was repeated for cases with a method 6 (i.e. coding undertaken in the registry after examination of the pathology report, which would enhance accuracy), the likelihood of death was 13% (95% CI 5-21%) higher in females than in males.
CONCLUSIONS: The NSW analysis controls for variability in coding, extent of disease at diagnosis and histological type of cancer. The analysis shows significantly lower survival from bladder cancer in NSW women compared with men, with no improvement in survival from 1980 to 2003. Possible reasons for the lower survivals in women, the lack of improvement in survival and coding differences in jurisdictions are discussed.

Entities:  

Mesh:

Year:  2009        PMID: 19338538     DOI: 10.1111/j.1464-410X.2009.08527.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  14 in total

Review 1.  Impact of gender on bladder cancer incidence, staging, and prognosis.

Authors:  Harun Fajkovic; Joshua A Halpern; Eugene K Cha; Atessa Bahadori; Thomas F Chromecki; Pierre I Karakiewicz; Eckart Breinl; Axel S Merseburger; Shahrokh F Shariat
Journal:  World J Urol       Date:  2011-06-09       Impact factor: 4.226

2.  A comprehensive evaluation of bladder cancer epidemiology and outcomes in Australia.

Authors:  Rajkumar Cheluvappa; David P Smith; Sabina Cerimagic; Manish I Patel
Journal:  Int Urol Nephrol       Date:  2014-02-01       Impact factor: 2.370

3.  Female sex is an independent risk factor for reduced overall survival in bladder cancer patients treated by transurethral resection and radio- or radiochemotherapy.

Authors:  Bastian Keck; Oliver J Ott; Lothar Häberle; Frank Kunath; Christian Weiss; Claus Rödel; Rolf Sauer; Rainer Fietkau; Bernd Wullich; Frens S Krause
Journal:  World J Urol       Date:  2012-10-23       Impact factor: 4.226

Review 4.  Radical Cystectomy in Female Patients - Improving Outcomes.

Authors:  Nikolaos Kalampokis; Nikolaos Grivas; Markus Ölschläger; Fahmy Nabil Hassan; Georgios Gakis
Journal:  Curr Urol Rep       Date:  2019-11-28       Impact factor: 3.092

5.  Trends of incidence and prognosis of primary adenocarcinoma of the bladder.

Authors:  Haowen Lu; Weidong Zhu; Weipu Mao; Feng Zu; Yali Wang; Wenchao Li; Bin Xu; Lihua Zhang; Ming Chen
Journal:  Ther Adv Urol       Date:  2021-05-24

Review 6.  Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature.

Authors:  Andrea Mari; Riccardo Campi; Riccardo Tellini; Giorgio Gandaglia; Simone Albisinni; Mohammad Abufaraj; Georgios Hatzichristodoulou; Francesco Montorsi; Roland van Velthoven; Marco Carini; Andrea Minervini; Shahrokh F Shariat
Journal:  World J Urol       Date:  2017-11-16       Impact factor: 4.226

7.  Identifying incident colorectal and lung cancer cases in health service utilisation databases in Australia: a validation study.

Authors:  David Goldsbury; Marianne Weber; Sarsha Yap; Emily Banks; Dianne L O'Connell; Karen Canfell
Journal:  BMC Med Inform Decis Mak       Date:  2017-02-27       Impact factor: 2.796

8.  Nomograms to Predict Individual Prognosis of Patients with Primary Small Cell Carcinoma of the Bladder.

Authors:  Fan Dong; Yifan Shen; Fengbin Gao; Xiao Shi; Tianyuan Xu; Xianjin Wang; Xiaohua Zhang; Shan Zhong; Minguang Zhang; Shanwen Chen; Zhoujun Shen
Journal:  J Cancer       Date:  2018-03-08       Impact factor: 4.207

9.  Survival analysis of patients with bladder cancer, life table approach.

Authors:  Abbas Rezaianzadeh; Abolfazl Mohammadbeigi; Jafar Mobaleghi; Narges Mohammadsalehi
Journal:  J Midlife Health       Date:  2012-07

10.  Poor survival of females with bladder cancer is limited to those aged 70 years or over: a population-wide linkage study, New South Wales, Australia.

Authors:  Manish I Patel; Albert Bang; David Gillett; Rajkumar Cheluvappa; David P Smith
Journal:  Cancer Med       Date:  2015-04-27       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.